Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-21-046683

Chief Medical Officer sold 2,631 shares at $16.98 ($44,675)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Gordon David N. Chief Medical Officer 2021-07-13 Sale −2,631 $16.98 $44,675 147,447 D: show line 1 in the form
Open-market sales · 2,631 sh · avg $16.98 · $44,675
Loading xslF345X03/doc4.xml…